Overall, our study is designed to investigate the expression rate of lamin B1 in normal breast epithelium, primary breast invasive carcinoma tissue that was not exposed to senescence-inducing therapy and in primary breast invasive carcinoma tissue that was exposed to senescence-inducing chemotherapy. Here, LMNB1 is linked to invasive breast carcinoma.